Start free trial
Trending New Genres Authors
EnglishEnglish
EspañolSpanish
简体中文Chinese
繁體中文Chinese (Traditional)
FrançaisFrench
DeutschGerman
日本語Japanese
PortuguêsPortuguese
ItalianoItalian
한국어Korean
РусскийRussian
NederlandsDutch
العربيةArabic
PolskiPolish
हिन्दीHindi
Tiếng ViệtVietnamese
SvenskaSwedish
ΕλληνικάGreek
TürkçeTurkish
ไทยThai
ČeštinaCzech
RomânăRomanian
MagyarHungarian
УкраїнськаUkrainian
IndonesiaIndonesian
DanskDanish
SuomiFinnish
БългарскиBulgarian
עבריתHebrew
NorskNorwegian
HrvatskiCroatian
CatalàCatalan
SlovenčinaSlovak
LietuviųLithuanian
SlovenščinaSlovenian
СрпскиSerbian
EestiEstonian
LatviešuLatvian
فارسیPersian
മലയാളംMalayalam
தமிழ்Tamil
اردوUrdu
Searching...
SoBrief
Rethinking Diabetes

Rethinking Diabetes

What Science Reveals About Diet, Insulin, and Successful Treatments
Diabetes diets rarely face decisive long-term trials. What should patients trust instead?
by Gary Taubes 2024 498 pages
4.17
500+ ratings
Listen
Immersive
V2.3
Amazon Kindle Audible
Try Full Access for 3 Days
Unlock listening & more!
Continue

Key Takeaways

Demand head-to-head diet trials before treating diabetes advice as settled science

The evidence gap. Diet is routinely described as a foundation of diabetes care, yet Taubes argues that researchers have rarely compared substantially different diets in the long-term trials needed to identify the safest, most effective approach. A 2019 American Diabetes Association consensus report found insufficient evidence to name a preferred eating pattern. Low-carbohydrate diets had been tested more often than alternatives over the previous two decades and showed the most consistent short-term benefits, but that is not the same as proof of long-term superiority.

Why it matters. The book notes that diagnosed diabetes in the United States rose about 600 percent from the early 1960s to 2015. Rising prevalence does not prove that standard dietary advice caused harm. It does make the missing comparison consequential: people need to know how different approaches affect blood sugar, complications, safety, and daily life over time.

Analysis

What's striking is the difference between a guideline that makes a reasonable public-health guess and a treatment whose benefits have been directly compared with alternatives. In a chronic disease, those can quietly become confused. The book is most persuasive when it asks what has actually been tested, for how long, and against what. The same standard should apply to low-carbohydrate diets: consistent short-term findings are a reason to investigate, not a substitute for long-term evidence. The practical lesson is intellectual rather than dietary: ask whether a recommendation rests on direct comparison or on expert judgment filling a gap.

Separate insulin deficiency from resistance before generalizing diabetes treatment

Two different failures. Type 1 diabetes occurs when the body produces too little insulin, so insulin treatment is essential for survival. Type 2, which accounts for roughly 90 to 95 percent of diagnoses in the book's account, usually begins with insulin resistance: the body responds poorly to insulin, and the pancreas compensates by making more. Blood sugar can be high even while insulin levels are high. In later stages, the pancreas may no longer keep up.

Why categories matter. Both conditions can produce elevated blood sugar, but a shared symptom does not establish a shared cause. Taubes argues that treating diet advice as interchangeable across the two forms obscures important differences in physiology and risk. A strategy that changes the amount of insulin a person needs may have very different consequences for someone who depends on injected insulin than for someone with type 2 diabetes.

Analysis

The distinction illustrates a basic rule of clinical reasoning: similar symptoms can arise from different mechanisms, and treatments act on mechanisms, not labels alone. Separating insulin deficiency from insulin resistance also clarifies why the same dietary or drug intervention cannot be assumed to have identical effects across patients. The book's account can make the categories sound more sharply divided than real clinical variation may be. Even so, insisting on mechanism before generalization is a useful safeguard against turning one successful treatment story into a universal prescription.

Treat remarkable diet successes as clues, not proof of long-term protection

One striking survivor. Before insulin was available, a Montana farmer with diabetes was prescribed a severely restricted diet. When insulin became available in 1922, his Mayo Clinic physicians shifted him to a much higher-calorie diet in which more than 80 percent of calories came from fat. He followed the plan for nearly three decades. In 1950, at age sixty-one, his examination showed no major signs of the vascular, eye, or kidney complications doctors expected.

A case, not a trial. The physicians could not establish whether his diet contributed to his good health. He was one patient, with no comparable control group, and his outcome cannot reveal what would have happened under another diet. Still, the case unsettled the assumption that a high-fat diabetic diet must be dangerous. Taubes uses such episodes to show how clinical observations can reveal questions that accepted theories overlook.

Analysis

The farmer's story is memorable because it creates a genuine scientific puzzle: a patient appears to thrive under a regimen later regarded as hazardous. Case reports are excellent at generating hypotheses, particularly when an outcome conflicts with expectations. They are poor at estimating how often the outcome occurs or what caused it. This distinction protects both sides of the argument. The case does not vindicate high-fat diets, but dismissing it as irrelevant would also discard a reason to investigate the treatment history more carefully.

Insulin rescued dying patients, then made every meal a dosing problem

A medical rescue. In 1922, thirteen-year-old Leonard Thompson was near death from severe diabetes. After receiving a more purified insulin extract, his blood sugar and ketones fell, and he regained strength. Insulin transformed type 1 diabetes from a rapidly fatal illness into a condition many people could live with for decades. It did not cure the disease, however, and doctors soon faced a new challenge: matching injected insulin to food and activity.

A difficult balance. Too much insulin can cause hypoglycemia, dangerously low blood sugar. Too little can leave blood sugar high. The right dose depends on meal size and composition, timing, exercise, illness, digestion, and individual response. Physicians began allowing more carbohydrates, partly to prevent low blood sugar, while using insulin to cover them. That offered more freedom at meals, but made blood sugar control a complicated, lifelong balancing act.

Analysis

Insulin's history shows why a breakthrough can change not just outcomes but the problem clinicians think they are solving. The immediate victory was preventing coma and death. Long-term questions about dosing, complications, and quality of life became visible only because patients survived. That is a recurring feature of chronic care: extending life can reveal burdens that were once hidden by early mortality. The book does not diminish insulin's lifesaving role. It asks readers to see both sides of the bargain, especially when a treatment's success creates new demands on patients.

See insulin as a fuel regulator, not merely a blood-sugar switch

More than glucose control. Insulin helps cells take up glucose, but it also promotes the storage of fat and glycogen, supports protein building, and limits the release of stored fat. Taubes describes this broad coordination of available and stored energy as fuel partitioning. The body uses food and stored fuel through interacting signals, rather than through isolated systems.

A measurement changed the picture. In 1960, researchers Rosalyn Yalow and Solomon Berson introduced the radioimmunoassay, a method that could measure tiny quantities of hormones in blood. Their work helped show that many people with type 2 diabetes have high insulin alongside high blood sugar, consistent with insulin resistance rather than simple insulin shortage. Taubes argues that this broader view raises questions about diet, fat storage, and treatment, while acknowledging that mechanisms alone cannot prove which diet produces better long-term outcomes.

Analysis

This perspective is valuable because it resists a common form of reductionism: defining a hormone by the one measurement most convenient to track. A system-level view makes it easier to see why changing one input can affect weight, blood sugar, and other processes at once. It also raises the evidentiary bar. A plausible mechanism is not a clinical outcome, and a hormone's role in fat storage does not by itself establish that a particular diet prevents complications. Mechanism guides the experiment; it should not be mistaken for the experiment's result.

Smaller carbohydrate loads can make insulin dosing less volatile

Feedback replaced guesswork. Richard Bernstein, an engineer with type 1 diabetes, began using a home blood-glucose meter in 1970. Although urine tests had suggested that his diabetes was controlled, repeated measurements showed his blood sugar ranging from about 40 to 400 milligrams per deciliter. He then tested how meals, exercise, and insulin affected his readings, making adjustments based on the results.

Small inputs, smaller errors. Bernstein called his approach the laws of small numbers: when both carbohydrate intake and insulin doses are smaller, he argued, errors in estimating food or insulin have less room to produce large swings. His method led him to sharply restrict carbohydrates and use smaller insulin doses. This is a report of his approach, not a universal instruction. People using insulin face serious risks from dosing changes and require clinical guidance; the book's broader point is that better measurement can expose problems hidden by averages or occasional tests.

Analysis

Bernstein's story joins two ideas often separated in medicine: patient experience and technical measurement. A device made his body's responses visible, while repeated trials gave him feedback that a monthly appointment could not provide. This resembles engineering control systems, where frequent measurements can make adjustments more precise. Yet data do not interpret themselves. A meter can reveal a pattern without establishing the safest response, and an individual's success cannot determine how well a method generalizes. Measurement is powerful when paired with careful interpretation and appropriate support.

Don't call patients noncompliant before testing whether the diet helps

Adherence is evidence. When patients struggled to follow prescribed diets, clinicians often concluded that the restrictions were too burdensome or that patients lacked discipline. Taubes offers another possibility: advice that does not improve how people feel or function may be difficult to sustain for good reason. In his account, doctors sometimes relaxed restrictions while assuming patients would prefer medication to dietary change, without testing that preference directly.

A major test had limits. The Look AHEAD trial followed more than 5,100 people with type 2 diabetes. Its intensive program combined calorie reduction, a low-fat diet, and increased exercise. Participants maintained an average weight loss of about 6 percent over eight years and saw several quality-of-life benefits, but the program did not reduce heart attacks or strokes. The trial tested that particular package, not every diet or every possible route to weight loss.

Analysis

Adherence is often treated as a character judgment when it may be information about the fit between an intervention and a person's life or physiology. This reframing improves care because it turns a failed plan into a question to investigate rather than a patient to blame. Look AHEAD also illustrates why bundled interventions complicate interpretation: calorie restriction, food composition, exercise, and intensive support were delivered together. Its null cardiovascular result cannot identify which ingredient mattered, or settle what a different dietary approach might do.

Promising low-carb results are not proof of safety or durability

Encouraging signals. In the Virta Health program, adults with type 2 diabetes received ongoing remote support while following a very-low-carbohydrate diet. Of 262 participants who began, 194 remained in the program at two years. Those continuing lost an average of about thirty pounds, lowered their average A1C by 1.3 percentage points, and reduced diabetes medications. More than half met the study's definition of partial remission, while 17 percent reached complete remission.

Important limits. The study was not randomized, and participants chose whether to join the program. Its results cannot show that diet alone caused the changes or predict how well the approach would work for everyone. A survey of more than 300 TypeOneGrit members with type 1 diabetes also reported unusually low A1C levels, but selection bias is possible. For type 1 diabetes, insulin adjustment, hypoglycemia, ketoacidosis, and children's growth make careful medical supervision essential.

Analysis

These findings deserve attention because they challenge the assumption that type 2 diabetes must always worsen despite treatment. They also demonstrate why impressive results and strong evidence are not synonyms. Participants selected into the program, received intensive support, and were not randomly assigned to an equivalent alternative. Those features leave open whether the benefits came from the diet, the support, selection, or their combination. The type 1 survey is even less suited to estimating risk across the whole patient population. The proper response is neither dismissal nor automatic adoption, but rigorous comparison and monitoring.

Judge diabetes advice by its comparator, outcome, and patient burden

Consensus has a history. Taubes traces how fear of dietary fat helped push diabetes advice toward low-fat, higher-carbohydrate eating after insulin made carbohydrate consumption easier to manage. That shift drew support from a heart-disease hypothesis linking saturated fat to cholesterol, while competing ideas emphasized sugar, refined carbohydrates, or low fiber. The book argues that the evidence behind these dietary stories was often incomplete. It does not follow that any rival explanation, or any alternative diet, is therefore correct.

Ask what the study measured. A trial may test medication rather than food, blood sugar rather than complications, or a specific weight-loss program rather than weight loss in general. Patients also experience treatment through daily effort, side effects, cost, and quality of life. The book's closing challenge is to make those outcomes visible and to support informed discussion between patients and clinicians while stronger comparative evidence remains incomplete.

Analysis

A useful way to read the book is as an audit of how a plausible theory becomes routine care. Each step can be reasonable on its own: experts interpret uncertain data, organizations issue guidance, and clinicians act before perfect evidence exists. The danger arises when a provisional choice becomes difficult to question. Still, consensus is not automatically groupthink, and disagreement is not automatically insight. Patients and clinicians need evidence that is both methodologically sound and relevant to the person being treated, with uncertainty made explicit rather than concealed.

Analysis

The book's central achievement is to make diabetes dietary advice a problem in the history and philosophy of medicine, not merely a contest between menus. Its strongest argument is about evidentiary asymmetry: drug strategies have been tested in large trials, while distinct dietary strategies have seldom received comparable long-term evaluation. The history of insulin, Elliott Joslin's influence, the changing fear of dietary fat, and the late arrival of home glucose monitoring make that gap concrete. The book also shows how measurements shape theory. When blood sugar is the most visible variable, clinicians may build treatments around it while overlooking insulin's wider effects or the patient's lived experience.

The case for carbohydrate restriction is less conclusive than the critique of existing evidence. Mechanisms involving insulin, fat storage, and glucose metabolism make the proposal biologically plausible. Virta's results and the TypeOneGrit survey are meaningful signals, but neither provides a randomized, long-term comparison capable of establishing universal effectiveness or safety. The distinction matters especially for type 1 diabetes, where insulin remains essential and dosing errors can be acute. A convincing account of how a consensus formed cannot, by itself, prove that the consensus is wrong.

The most useful reading therefore holds two propositions together. Standard dietary guidance should not receive immunity from scrutiny merely because it is familiar or officially endorsed. Alternative diets should not receive immunity because they are historically old, mechanistically appealing, or successful for selected patients. The proper unit of evaluation is a defined intervention compared with a credible alternative, over a meaningful duration, using outcomes patients value as well as laboratory measures. That includes complications, hypoglycemia, weight, treatment burden, and quality of life. Taubes's history is most valuable as a demand for better questions and more honest uncertainty, not as a substitute for individualized medical care or definitive comparative trials.

Summary in 30 Seconds
Type 1 diabetes stems from inadequate insulin, while type 2 usually begins with insulin resistance, so similar blood sugar readings can reflect different problems. Insulin regulates fuel storage as well as glucose, and matching doses to meals can be difficult. Smaller carbohydrate loads may reduce dosing swings, but promising low-carb results remain short-term or nonrandomized. Sound advice requires head-to-head trials that measure complications, safety, quality of life, and treatment burden.
Contains spoilers

Last updated:

Report Issue

Review Summary

4.17 out of 5
Average of 500+ ratings from Goodreads and Amazon.

Rethinking Diabetes receives mostly positive reviews for its comprehensive history of diabetes treatment and critique of conventional approaches. Readers appreciate Taubes' thorough research and insights into low-carb diets for managing diabetes. Some find the book dense and repetitive, while others consider it eye-opening. Critics note potential bias and lack of medical credentials. Many readers recommend it for diabetics and healthcare professionals, praising its historical context and challenging of mainstream dietary advice. Overall, it's seen as an important contribution to the diabetes discussion.

Your rating:
4.62
173 ratings
Want to read the full book?

Glossary

homeostasis

stable internal conditions

The body's ongoing regulation of its internal environment so cells can function within healthy limits. In the book, blood sugar is one example: hormones and organs respond to changing food, activity, and fuel availability to keep glucose from rising or falling too far. Diabetes is presented as a failure in this interconnected regulatory system.

insulin resistance

reduced response to insulin

A condition in which cells respond less effectively to insulin's signals. In type 2 diabetes, the pancreas may initially compensate by releasing more insulin, so elevated insulin and elevated blood sugar can occur together. The condition differs from type 1 diabetes, in which the body produces too little insulin and external insulin is required for survival.

radioimmunoassay

sensitive hormone measurement

A laboratory method developed by Rosalyn Yalow and Solomon Berson that uses radioactive markers and immune reactions to measure very small quantities of substances such as insulin in blood. Its application to insulin helped reveal that many people with type 2 diabetes have high circulating insulin, changing the understanding of the disease from simple insulin shortage to insulin resistance.

fuel partitioning

directing fuel use and storage

The body's allocation of energy from food and stored reserves among immediate use, storage, and tissue maintenance. Taubes emphasizes insulin's influence on this process: insulin supports glucose uptake and storage, encourages fat storage, and restrains fat release. The concept broadens the discussion of insulin beyond its familiar role in regulating blood glucose.

laws of small numbers

smaller inputs, smaller errors

Richard Bernstein's principle that smaller amounts of carbohydrate and smaller insulin doses can make blood sugar responses more predictable and reduce the size of dosing errors. Bernstein used the approach alongside frequent self-monitoring to manage type 1 diabetes. It is a proposed clinical strategy described in the book, not a guarantee of safety or a universal treatment recommendation.

Syndrome X

cluster of metabolic risk factors

Gerald Reaven's term for a group of abnormalities linked in his research: insulin resistance, poor blood-sugar control, high insulin, elevated triglycerides, low HDL cholesterol, and high blood pressure. Reaven argued that insulin resistance helped connect type 2 diabetes, obesity, and heart disease. The cluster was later more commonly called metabolic syndrome.

advanced glycation end products

sugar-damaged proteins

Compounds formed when glucose binds to proteins and subsequent chemical reactions make the change effectively irreversible. The book describes how these products can cross-link proteins, stiffening tissues and contributing to damage in organs affected by diabetes, including the eyes, kidneys, nerves, and arteries. They are also discussed in relation to tissue changes associated with aging.

Diabetes Control and Complications Trial

intensive versus standard insulin trial

A major study comparing intensive insulin treatment with standard treatment in people with type 1 diabetes. Intensive treatment reduced the onset and progression of microvascular complications, including eye, nerve, and kidney damage, but increased severe hypoglycemia and weight gain. The trial tested insulin-treatment strategies alongside conventional dietary guidance, not a low-carbohydrate diet against a standard diet.

Look AHEAD trial

lifestyle intervention in type 2

A large study of more than 5,100 overweight or obese adults with type 2 diabetes. It compared standard care with an intensive program combining calorie reduction, a low-fat diet, exercise, and behavioral support. Participants in the intensive program maintained modest weight loss and improved several quality-of-life measures, but the intervention did not reduce heart attacks or strokes.

nutritional ketosis

ketones from restricted carbohydrates

A metabolic state associated with eating very few carbohydrates, in which the body produces ketone bodies from fat for use as fuel. The book distinguishes this intended state, used in some carbohydrate-restricted programs, from diabetic ketoacidosis, a dangerous disorder involving severe metabolic disruption. The distinction does not mean a ketogenic diet is automatically safe, particularly for someone using insulin.

FAQ

What's Rethinking Diabetes about?

  • Exploration of diabetes management: The book delves into the historical and scientific perspectives on diabetes treatment, focusing on the roles of diet and insulin.
  • Challenges conventional wisdom: Gary Taubes critiques traditional approaches, particularly the emphasis on high-carbohydrate diets, and suggests a paradigm shift in understanding the disease.
  • Advocates for dietary change: Taubes proposes that a low-carbohydrate, high-fat diet may be more beneficial for managing diabetes than traditional recommendations.

Why should I read Rethinking Diabetes?

  • Challenges accepted beliefs: The book questions widely accepted dietary practices for diabetes management, offering alternative approaches that may be more effective.
  • Evidence-based insights: Taubes presents a well-researched narrative, drawing on scientific studies and historical data to support his arguments.
  • Broader health implications: Discussions extend beyond diabetes, touching on obesity and heart disease, making it relevant for anyone interested in health and nutrition.

What are the key takeaways of Rethinking Diabetes?

  • Diet is crucial: Taubes emphasizes the fundamental role of diet in diabetes management, challenging the notion that high-carbohydrate diets are suitable for all patients.
  • Insulin's dual role: The book discusses insulin as both a life-saving treatment and a potential contributor to complications if not managed properly.
  • Need for new paradigms: Taubes calls for a reevaluation of diabetes treatment paradigms, advocating for low-carbohydrate, high-fat diets as a more effective approach.

What are the best quotes from Rethinking Diabetes and what do they mean?

  • “Diet has always generated passion...”: This quote underscores the contentious nature of dietary recommendations, suggesting strong opinions often arise without solid evidence.
  • “The effect of any diet...”: Emphasizes the importance of patient adherence to dietary guidelines, indicating success should be evaluated based on real-world outcomes.
  • “If theoretically these errors...”: Suggests that correcting misconceptions about diet and diabetes could lead to better management strategies and improved outcomes.

How does Rethinking Diabetes redefine the role of insulin in diabetes management?

  • Insulin as a double-edged sword: Taubes discusses how insulin therapy can save lives but may also lead to complications if not managed carefully.
  • Focus on metabolic health: Managing insulin levels and understanding their effects on metabolism is crucial for effective diabetes treatment.
  • Balanced approaches needed: Taubes advocates for strategies that minimize reliance on high doses of insulin while promoting dietary changes.

What is the historical context of diabetes treatment discussed in Rethinking Diabetes?

  • Early dietary practices: The book outlines how early physicians recommended high-fat diets for diabetes management before insulin's discovery.
  • Shift to carbohydrate-rich diets: After insulin became available, dietary recommendations shifted towards high-carbohydrate diets, which Taubes argues may not benefit all patients.
  • Influence of key figures: Taubes discusses the impact of influential diabetologists like Elliott Joslin and Frederick Allen on modern dietary guidelines.

What specific dietary advice does Rethinking Diabetes offer?

  • Low-carbohydrate emphasis: Taubes advocates for a low-carbohydrate diet as a primary strategy for managing diabetes, arguing it can improve blood sugar levels.
  • Focus on whole foods: Encourages the consumption of whole, unprocessed foods over refined carbohydrates and sugars for better nutritional value.
  • Individualized dietary plans: Emphasizes tailoring dietary plans to individual needs and responses, working closely with healthcare providers.

How does Rethinking Diabetes address the relationship between insulin and weight gain?

  • Insulin's anabolic effects: Taubes discusses how insulin promotes fat storage, which can lead to weight gain, crucial for diabetes management.
  • Dietary influence on insulin levels: Different diets affect insulin levels and weight management, with low-carbohydrate diets helping reduce insulin levels.
  • Long-term implications: Relying solely on insulin therapy without dietary considerations can lead to weight gain and complications.

What is the Bernstein Method mentioned in Rethinking Diabetes?

  • Self-monitoring focus: Emphasizes the importance of self-monitoring blood sugar levels to understand how different foods affect glycemic control.
  • Low-carbohydrate diet: Advocates for a very low-carbohydrate diet to achieve normal blood sugar levels and minimize insulin requirements.
  • Individualized insulin dosing: Involves precise insulin dosing based on specific carbohydrate content of meals for better blood sugar control.

How does Rethinking Diabetes propose to revolutionize diabetes care?

  • Patient-centric approach: Advocates for empowering individuals to monitor their own blood sugar and make informed dietary choices.
  • Emphasis on diet: Proposes dietary changes, particularly reducing carbohydrate intake, to improve diabetes management and reduce medication reliance.
  • Integration of technology: Highlights the use of technology, such as continuous glucose monitors, to enhance self-management and informed decision-making.

What are the criticisms of current diabetes management practices discussed in Rethinking Diabetes?

  • Overreliance on insulin: Criticizes the heavy reliance on insulin therapy without adequate dietary considerations, leading to potential complications.
  • Flawed dietary guidelines: Points out that current guidelines may not be effective for all patients and are often based on outdated science.
  • Lack of individualization: Emphasizes the need for personalized strategies, as one-size-fits-all approaches dominate treatment plans.

What are the implications of Rethinking Diabetes for future diabetes research?

  • Need for reevaluation: Calls for reevaluating existing research and guidelines, focusing on the impact of low-carbohydrate diets.
  • Individualized approaches: Future research should prioritize personalized treatment strategies for more effective management.
  • Exploration of alternative therapies: Suggests exploring dietary changes and lifestyle modifications beyond traditional insulin treatment.

About the Author

Gary Taubes is an American science writer known for his investigative journalism in medicine and nutrition. With degrees in applied physics, aerospace engineering, and journalism, Taubes has authored several books on scientific controversies. His work focuses on challenging conventional wisdom in nutrition, particularly regarding carbohydrates and insulin's role in fat storage. Gary Taubes gained prominence with "Good Calories, Bad Calories" and "Why We Get Fat," which argue against the low-fat diet paradigm. His writing style combines thorough research with accessible explanations for general readers. Taubes' work has sparked debates in the scientific community and influenced public understanding of diet and health.

Download PDF

To save this Rethinking Diabetes summary for later, download the free PDF. You can print it out, or read offline at your convenience.
Download PDF
File size: 0.39 MB     Pages: 21

Download EPUB

To read this Rethinking Diabetes summary on your e-reader device or app, download the free EPUB. The .epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.
Download EPUB
File size: 1.41 MB     Pages: 26
Want to read the full book?
Follow
Listen1 mins
Home
Swipe
Library
Get App
Try Full Access for 3 Days
Listen, bookmark, and more
Compare Features Free Pro
📖 Read Summaries
Read unlimited summaries. Free users get 3 per month
🎧 Listen to Summaries
Listen to unlimited summaries in 40 languages
—
❤️ Unlimited Bookmarks
Free users are limited to 4
—
📜 Unlimited History
Free users are limited to 4
—
📥 Unlimited Downloads
Free users are limited to 1
—
Risk-Free Timeline
Today: Get Instant Access
Listen to full summaries of 26,000+ books. That's 12,000+ hours of audio!
Day 2: Trial Reminder
We'll send you a notification that your trial is ending soon.
Day 3: Your subscription begins
You'll be charged on Nov 25,
cancel anytime before.
Consume 2.8× More Books
2.8× more books Listening Reading
Our users love us
1M+ readers
Trustpilot Rating
TrustPilot
4.6 Excellent
This site is a total game-changer. I've been flying through book summaries like never before. Highly, highly recommend.
— Dave G
Worth my money and time, and really well made. I've never seen this quality of summaries on other websites. Very helpful!
— Em
Highly recommended!! Fantastic service. Perfect for those that want a little more than a teaser but not all the intricate details of a full audio book.
— Greg M
Save 62%
Yearly
$119.88 $44.99/year/yr
$3.75/mo
Monthly
$9.99/mo
Start a 3-Day Free Trial
3 days free, then $44.99/year. Cancel anytime.
Unlock a world of fiction & nonfiction books
26,000+ books for the price of 2 books
Read any book in 10 minutes
Discover new books like Tinder
Request any book if it's not summarized
Read more books than anyone you know
#1 app for book lovers
Lifelike & immersive summaries
30-day money-back guarantee
Download summaries in EPUBs or PDFs
Cancel anytime in a few clicks

Why one summary?

Scanner
Find a barcode to scan

⭐
⭐
⭐
We have a special gift for you
Open
38% off
DISCOUNT FOR YOU
⭐
⭐
⭐
$79.99
$49.99/year
Only $4.16 per month
Continue
2 taps to start, super easy to cancel
Settings
General
Widget
Loading...